According to clinical research, Farxiga, either alone or in conjunction with other diabetic drugs (such as GLP-1 agonists, insulin, or metformin), can reduce HbA1c levels by an average of roughly 0.5% to 1%
GLP-1 receptor agonists are not suitable for everyone
Factors influencing this decision include: GI sensitivity Blood sugar control needs Medication half-life I personally have seen patients switch without the need for a washout period except for on rare occasions when they experience severe side effects from semaglutide Potential Benefits of Switching to Tirzepatide Potential Benefits of Switching to Tirzepatide Switching from semaglutide to tirzepatide may offer several potential benefits, especially for individuals who havent achieved their target weight or glycemic control
Discussion Our systematic review demonstrates that GLP-1 receptor agonists (GLP-1 RAs), including semaglutide, liraglutide, tirzepatide, and exenatide, offer sustained efficacy in weight management, with consistent improvements in glycemic control among patients with obesity or overweight
.jpg)
